世界の血管麻痺ショック用バソプレシン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Vasopressin for Vasoplegic Shock Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6063
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、血管麻痺ショック用バソプレシンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（敗血症、心臓手術後、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・血管麻痺ショック用バソプレシンの市場動向
・企業の競争状況、市場シェア
・血管麻痺ショック用バソプレシンの種類別市場規模と予測2016-2027（静脈注射、筋肉注射、皮下注射）
・血管麻痺ショック用バソプレシンの用途別市場規模と予測2016-2027（敗血症、心臓手術後、その他）
・血管麻痺ショック用バソプレシンの北米市場規模2016-2027（アメリカ、カナダ）
・血管麻痺ショック用バソプレシンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・血管麻痺ショック用バソプレシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・血管麻痺ショック用バソプレシンの中南米市場規模2016-2027（メキシコ、ブラジル）
・血管麻痺ショック用バソプレシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Endo International、AMOMED Pharma、La Jolla Pharmaceutical Company、Pfizer、Ferring Pharmaceuticals、Fresenius Kabi、Astellas Pharma、Eagle Pharmaceuticals）
・結論

Vasoplegia is a type of syndrome that involves pathologically low systemic vascular resistance. It further leads to reduced blood pressure amid presence of a raised cardiac output. Vasopressin is an antidiuretic hormone directed to be used for the treatment and prevention of postoperative abdominal distention in abdominal roentgenography. lt is mosty used as an intensive care medicine.Vasopressin infusion efficiently increases systemic vascular resistance and arterial pressure while improving survival chances in patients. Additionally, it decreases catecholamine vasopressors requirements in the patient with or at the risk of vasoplegic syndrome after cardiac surgery.

Market Analysis and Insights: Global Vasopressin for Vasoplegic Shock Market
The global Vasopressin for Vasoplegic Shock market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vasopressin for Vasoplegic Shock market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vasopressin for Vasoplegic Shock market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vasopressin for Vasoplegic Shock market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vasopressin for Vasoplegic Shock market.

Global Vasopressin for Vasoplegic Shock Scope and Market Size
Vasopressin for Vasoplegic Shock market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vasopressin for Vasoplegic Shock market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection

Segment by Application
Sepsis
Post Cardiac Surgery
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Endo International
AMOMED Pharma
La Jolla Pharmaceutical Company
Pfizer
Ferring Pharmaceuticals
Fresenius Kabi
Astellas Pharma
Eagle Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasopressin for Vasoplegic Shock Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Injection
1.2.3 Intramuscular Injection
1.2.4 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Vasopressin for Vasoplegic Shock Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sepsis
1.3.3 Post Cardiac Surgery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vasopressin for Vasoplegic Shock Market Perspective (2016-2027)
2.2 Vasopressin for Vasoplegic Shock Growth Trends by Regions
2.2.1 Vasopressin for Vasoplegic Shock Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vasopressin for Vasoplegic Shock Historic Market Share by Regions (2016-2021)
2.2.3 Vasopressin for Vasoplegic Shock Forecasted Market Size by Regions (2022-2027)
2.3 Vasopressin for Vasoplegic Shock Industry Dynamic
2.3.1 Vasopressin for Vasoplegic Shock Market Trends
2.3.2 Vasopressin for Vasoplegic Shock Market Drivers
2.3.3 Vasopressin for Vasoplegic Shock Market Challenges
2.3.4 Vasopressin for Vasoplegic Shock Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vasopressin for Vasoplegic Shock Players by Revenue
3.1.1 Global Top Vasopressin for Vasoplegic Shock Players by Revenue (2016-2021)
3.1.2 Global Vasopressin for Vasoplegic Shock Revenue Market Share by Players (2016-2021)
3.2 Global Vasopressin for Vasoplegic Shock Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vasopressin for Vasoplegic Shock Revenue
3.4 Global Vasopressin for Vasoplegic Shock Market Concentration Ratio
3.4.1 Global Vasopressin for Vasoplegic Shock Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasopressin for Vasoplegic Shock Revenue in 2020
3.5 Vasopressin for Vasoplegic Shock Key Players Head office and Area Served
3.6 Key Players Vasopressin for Vasoplegic Shock Product Solution and Service
3.7 Date of Enter into Vasopressin for Vasoplegic Shock Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vasopressin for Vasoplegic Shock Breakdown Data by Type
4.1 Global Vasopressin for Vasoplegic Shock Historic Market Size by Type (2016-2021)
4.2 Global Vasopressin for Vasoplegic Shock Forecasted Market Size by Type (2022-2027)

5 Vasopressin for Vasoplegic Shock Breakdown Data by Application
5.1 Global Vasopressin for Vasoplegic Shock Historic Market Size by Application (2016-2021)
5.2 Global Vasopressin for Vasoplegic Shock Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vasopressin for Vasoplegic Shock Market Size (2016-2027)
6.2 North America Vasopressin for Vasoplegic Shock Market Size by Type
6.2.1 North America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021)
6.2.2 North America Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027)
6.2.3 North America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2027)
6.3 North America Vasopressin for Vasoplegic Shock Market Size by Application
6.3.1 North America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021)
6.3.2 North America Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027)
6.3.3 North America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2027)
6.4 North America Vasopressin for Vasoplegic Shock Market Size by Country
6.4.1 North America Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021)
6.4.2 North America Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vasopressin for Vasoplegic Shock Market Size (2016-2027)
7.2 Europe Vasopressin for Vasoplegic Shock Market Size by Type
7.2.1 Europe Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021)
7.2.2 Europe Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027)
7.2.3 Europe Vasopressin for Vasoplegic Shock Market Size by Type (2016-2027)
7.3 Europe Vasopressin for Vasoplegic Shock Market Size by Application
7.3.1 Europe Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021)
7.3.2 Europe Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027)
7.3.3 Europe Vasopressin for Vasoplegic Shock Market Size by Application (2016-2027)
7.4 Europe Vasopressin for Vasoplegic Shock Market Size by Country
7.4.1 Europe Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021)
7.4.2 Europe Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size (2016-2027)
8.2 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type
8.2.1 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type (2016-2027)
8.3 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application
8.3.1 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application (2016-2027)
8.4 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Region
8.4.1 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vasopressin for Vasoplegic Shock Market Size (2016-2027)
9.2 Latin America Vasopressin for Vasoplegic Shock Market Size by Type
9.2.1 Latin America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021)
9.2.2 Latin America Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027)
9.2.3 Latin America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2027)
9.3 Latin America Vasopressin for Vasoplegic Shock Market Size by Application
9.3.1 Latin America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021)
9.3.2 Latin America Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027)
9.3.3 Latin America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2027)
9.4 Latin America Vasopressin for Vasoplegic Shock Market Size by Country
9.4.1 Latin America Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021)
9.4.2 Latin America Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size (2016-2027)
10.2 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type
10.2.1 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type (2016-2027)
10.3 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application
10.3.1 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application (2016-2027)
10.4 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Country
10.4.1 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Endo International
11.1.1 Endo International Company Details
11.1.2 Endo International Business Overview
11.1.3 Endo International Vasopressin for Vasoplegic Shock Introduction
11.1.4 Endo International Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.1.5 Endo International Recent Development
11.2 AMOMED Pharma
11.2.1 AMOMED Pharma Company Details
11.2.2 AMOMED Pharma Business Overview
11.2.3 AMOMED Pharma Vasopressin for Vasoplegic Shock Introduction
11.2.4 AMOMED Pharma Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.2.5 AMOMED Pharma Recent Development
11.3 La Jolla Pharmaceutical Company
11.3.1 La Jolla Pharmaceutical Company Company Details
11.3.2 La Jolla Pharmaceutical Company Business Overview
11.3.3 La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Introduction
11.3.4 La Jolla Pharmaceutical Company Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.3.5 La Jolla Pharmaceutical Company Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Vasopressin for Vasoplegic Shock Introduction
11.4.4 Pfizer Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Ferring Pharmaceuticals
11.5.1 Ferring Pharmaceuticals Company Details
11.5.2 Ferring Pharmaceuticals Business Overview
11.5.3 Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Introduction
11.5.4 Ferring Pharmaceuticals Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.5.5 Ferring Pharmaceuticals Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Vasopressin for Vasoplegic Shock Introduction
11.6.4 Fresenius Kabi Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Vasopressin for Vasoplegic Shock Introduction
11.7.4 Astellas Pharma Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.7.5 Astellas Pharma Recent Development
11.8 Eagle Pharmaceuticals
11.8.1 Eagle Pharmaceuticals Company Details
11.8.2 Eagle Pharmaceuticals Business Overview
11.8.3 Eagle Pharmaceuticals Vasopressin for Vasoplegic Shock Introduction
11.8.4 Eagle Pharmaceuticals Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021)
11.8.5 Eagle Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vasopressin for Vasoplegic Shock Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Intramuscular Injection
Table 4. Key Players of Subcutaneous Injection
Table 5. Global Vasopressin for Vasoplegic Shock Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Vasopressin for Vasoplegic Shock Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Vasopressin for Vasoplegic Shock Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Vasopressin for Vasoplegic Shock Market Share by Regions (2016-2021)
Table 9. Global Vasopressin for Vasoplegic Shock Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Vasopressin for Vasoplegic Shock Market Share by Regions (2022-2027)
Table 11. Vasopressin for Vasoplegic Shock Market Trends
Table 12. Vasopressin for Vasoplegic Shock Market Drivers
Table 13. Vasopressin for Vasoplegic Shock Market Challenges
Table 14. Vasopressin for Vasoplegic Shock Market Restraints
Table 15. Global Vasopressin for Vasoplegic Shock Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Vasopressin for Vasoplegic Shock Market Share by Players (2016-2021)
Table 17. Global Top Vasopressin for Vasoplegic Shock Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasopressin for Vasoplegic Shock as of 2020)
Table 18. Ranking of Global Top Vasopressin for Vasoplegic Shock Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Vasopressin for Vasoplegic Shock Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Vasopressin for Vasoplegic Shock Product Solution and Service
Table 22. Date of Enter into Vasopressin for Vasoplegic Shock Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Type (2016-2021)
Table 26. Global Vasopressin for Vasoplegic Shock Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Vasopressin for Vasoplegic Shock Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Application (2016-2021)
Table 30. Global Vasopressin for Vasoplegic Shock Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size by Country (2022-2027) & (US$ Million)
Table 62. Endo International Company Details
Table 63. Endo International Business Overview
Table 64. Endo International Vasopressin for Vasoplegic Shock Product
Table 65. Endo International Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 66. Endo International Recent Development
Table 67. AMOMED Pharma Company Details
Table 68. AMOMED Pharma Business Overview
Table 69. AMOMED Pharma Vasopressin for Vasoplegic Shock Product
Table 70. AMOMED Pharma Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 71. AMOMED Pharma Recent Development
Table 72. La Jolla Pharmaceutical Company Company Details
Table 73. La Jolla Pharmaceutical Company Business Overview
Table 74. La Jolla Pharmaceutical Company Vasopressin for Vasoplegic Shock Product
Table 75. La Jolla Pharmaceutical Company Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 76. La Jolla Pharmaceutical Company Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Vasopressin for Vasoplegic Shock Product
Table 80. Pfizer Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Ferring Pharmaceuticals Company Details
Table 83. Ferring Pharmaceuticals Business Overview
Table 84. Ferring Pharmaceuticals Vasopressin for Vasoplegic Shock Product
Table 85. Ferring Pharmaceuticals Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 86. Ferring Pharmaceuticals Recent Development
Table 87. Fresenius Kabi Company Details
Table 88. Fresenius Kabi Business Overview
Table 89. Fresenius Kabi Vasopressin for Vasoplegic Shock Product
Table 90. Fresenius Kabi Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 91. Fresenius Kabi Recent Development
Table 92. Astellas Pharma Company Details
Table 93. Astellas Pharma Business Overview
Table 94. Astellas Pharma Vasopressin for Vasoplegic Shock Product
Table 95. Astellas Pharma Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 96. Astellas Pharma Recent Development
Table 97. Eagle Pharmaceuticals Company Details
Table 98. Eagle Pharmaceuticals Business Overview
Table 99. Eagle Pharmaceuticals Revenue in Vasopressin for Vasoplegic Shock Business (2016-2021) & (US$ Million)
Table 100. Eagle Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasopressin for Vasoplegic Shock Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Injection Features
Figure 3. Intramuscular Injection Features
Figure 4. Subcutaneous Injection Features
Figure 5. Global Vasopressin for Vasoplegic Shock Market Share by Application: 2020 VS 2027
Figure 6. Sepsis Case Studies
Figure 7. Post Cardiac Surgery Case Studies
Figure 8. Others Case Studies
Figure 9. Vasopressin for Vasoplegic Shock Report Years Considered
Figure 10. Global Vasopressin for Vasoplegic Shock Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Vasopressin for Vasoplegic Shock Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Vasopressin for Vasoplegic Shock Market Share by Regions: 2020 VS 2027
Figure 13. Global Vasopressin for Vasoplegic Shock Market Share by Regions (2022-2027)
Figure 14. Global Vasopressin for Vasoplegic Shock Market Share by Players in 2020
Figure 15. Global Top Vasopressin for Vasoplegic Shock Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasopressin for Vasoplegic Shock as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Vasopressin for Vasoplegic Shock Revenue in 2020
Figure 17. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Type (2016-2021)
Figure 18. Global Vasopressin for Vasoplegic Shock Revenue Market Share by Type (2022-2027)
Figure 19. North America Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Vasopressin for Vasoplegic Shock Market Share by Type (2016-2027)
Figure 21. North America Vasopressin for Vasoplegic Shock Market Share by Application (2016-2027)
Figure 22. North America Vasopressin for Vasoplegic Shock Market Share by Country (2016-2027)
Figure 23. United States Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Vasopressin for Vasoplegic Shock Market Share by Type (2016-2027)
Figure 27. Europe Vasopressin for Vasoplegic Shock Market Share by Application (2016-2027)
Figure 28. Europe Vasopressin for Vasoplegic Shock Market Share by Country (2016-2027)
Figure 29. Germany Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Vasopressin for Vasoplegic Shock Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Vasopressin for Vasoplegic Shock Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Vasopressin for Vasoplegic Shock Market Share by Region (2016-2027)
Figure 39. China Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Vasopressin for Vasoplegic Shock Market Share by Type (2016-2027)
Figure 47. Latin America Vasopressin for Vasoplegic Shock Market Share by Application (2016-2027)
Figure 48. Latin America Vasopressin for Vasoplegic Shock Market Share by Country (2016-2027)
Figure 49. Mexico Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Vasopressin for Vasoplegic Shock Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Vasopressin for Vasoplegic Shock Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Vasopressin for Vasoplegic Shock Market Share by Country (2016-2027)
Figure 55. Turkey Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Vasopressin for Vasoplegic Shock Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Endo International Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 59. AMOMED Pharma Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 60. La Jolla Pharmaceutical Company Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 62. Ferring Pharmaceuticals Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 63. Fresenius Kabi Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 64. Astellas Pharma Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 65. Eagle Pharmaceuticals Revenue Growth Rate in Vasopressin for Vasoplegic Shock Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Global Extracorporeal Shock-wave Lithotripsy(ESWL) Market Size, Status and Forecast 2021-2027
QFJ1-4213 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、体外衝撃波結石破砕術（ESWL）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（X線体外衝撃波結石破砕術、B-超音波体外衝撃波結石破砕術、X線＆B-超音波体外衝撃波結石破砕術）、用途別市場規模（腎臓結...

世界の非外科的外側上顆炎治療市場規模・現状・予測（2021年-2027年）

Global Non-surgical Lateral Epicondylitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4595 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非外科的外側上顆炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（体外衝撃波療法、装具、薬物療法・理学療法、その他）、用途別市場規模（アスリート、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の電気刺激療法市場規模・現状・予測（2021年-2027年）

Global Electrical Stimulation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4178 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、電気刺激療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（体外衝撃波療法、干渉療法、磁場療法、超音波療法、経皮的電気刺激（TENS）療法、その他）、用途別市場規模（整形外科、心臓病学、泌尿器科、疼痛...

産業用油圧緩衝器のグローバル市場2021

Global Industrial Hydraulic Shock Absorber Sales Market Report 2021
QAF25837 2021年4月9日 145Pages
本市場調査資料では、世界の産業用油圧緩衝器市場について種類別（調整式油圧緩衝器、非調整式油圧緩衝器）、用途別（金属加工、ファクトリーオートメーション、マテリアルハンドリング＆パッケージング、製薬＆医療、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めまし...

世界の腎疝痛治療機器市場規模・現状・予測（2021年-2027年）

Global Renal Colic Treatment Equipments Market Size, Status and Forecast 2021-2027
QFJ1-4809 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、腎疝痛治療機器の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（体外衝撃波結石破砕術（ESWL）、尿管鏡検査（URS）、経皮的腎切石術（PCNL））、用途別市場規模（病院、専門センター、その他）、主要地...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の勃起不全治療市場規模・現状・予測（2021年-2027年）

Global Erectile Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4204 2021年6月 122Pages
QYResearch社発行の本調査レポートでは、勃起不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口治療、陰茎インプラント、真空収縮装置、衝撃波療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界の滅菌注射市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sterile Injection Market The global Sterile Injection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の医療用射出成形市場規模・現状・予測（2021年-2027年） Medical Injection moulding is a manufacturing process for producing parts by injecting molten material into a mould. Market Analysis and Insights: Global Medical Injection Molding Market The global Medical Injection Molding market size is projected to reach US$ 1383.4 million by 2027, from US$ 1146.…
注射用ミカファンギンナトリウムのグローバル市場2021 Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
世界のマイクロ射出成形市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Micro Injection Molding Market The global Micro Injection Molding market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
世界の粉末射出成形（PIM）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Powder Injection Molding(PIM) Market The global Powder Injection Molding(PIM) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…